###begin article-title 0
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M1/T1 </italic>
Females with paired occurrence of cancers in the UADT and genital region have a higher frequency of either Glutathione S-transferase M1/T1 null genotype
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 177 179 177 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 718 721 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 860 866 860 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 876 892 876 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">either GSTM1/T1 </italic>
###xml 1193 1198 1193 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 1199 1202 1199 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 641 649 <span type="species:ncbi:9606">patients</span>
###xml 772 779 <span type="species:ncbi:4097">tobacco</span>
Upper Aero digestive Tract (UADT) is the commonest site for the development of second cancer in females after primary cervical cancer. Glutathione S-transferase (GSTM1 and / or T1) null genotype modulates the risk of developing UADT cancer (primary as well as second cancer). The aim of this study was to evaluate the difference in GST null genotype frequencies in females with paired cancers in the UADT and genital region as compared to females with paired cancers in the UADT and non-genital region. Forty-nine females with a cancer in the UADT and another cancer (at all sites-genital and non-genital) were identified from a database of patients with multiple primary neoplasms and were analyzed for the GSTM1 and T1 genotype in addition to known factors such as age, tobacco habits, alcohol habits and family history of cancer. Frequencies of GSTM1 null, GSTT1 null, and either GSTM1/T1 null were higher in females with paired occurrence of cancer in the UADT and genital site (54%, 33% and 75% respectively) in comparison to females with paired occurrence of cancer in the UADT and non-genital sites (22%, 6% and 24% respectively). The significantly higher inherited frequency of either GSTM1/T1 null genotype in females with a paired occurrence of cancers in UADT and genital region (p = 0.01), suggests that these females are more susceptible to damage by carcinogens as compared to females who have UADT cancers in association with cancers at non-genital sites.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Precise risk estimation for the development of second cancers in the Head & Neck, Lung, and Esophagus, also known as the Upper Aero-Digestive Tract (UADT), is difficult due to the multifactorial origin and gene-environment interaction [1].
###end p 4
###begin p 5
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST</italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">alpha</italic>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mu</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">theta</italic>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pi </italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gamma </italic>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 742 748 742 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 752 754 752 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1</italic>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 800 801 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 135 142 <span type="species:ncbi:4097">tobacco</span>
###xml 606 614 <span type="species:ncbi:9606">Patients</span>
The Glutathione S transferase (GST) family of enzymes coded for by at least five distinct loci-alpha, mu, theta, pi and gamma detoxify tobacco carcinogens [2] and play an important role in the gene-environment interaction associated risk for cancer. The results of a recently published meta- and pooled- analysis of 4635 cases and 5770 controls, support the widely studied association of inherited GST genotype with the risk of developing squamous cell carcinomas (SCC) in the UADT. In addition the results support the notion that the risk increases when genotypes at multiple GST loci are considered [3]. Patients with second (synchronous and metachronous) cancers in the UADT also have a higher frequency of GST null genotype (particularly GSTM1 and T1) as compared to those with single cancers [4-7].
###end p 5
###begin p 6
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 115 136 <span type="species:ncbi:10566">Human Papilloma Virus</span>
###xml 138 141 <span type="species:ncbi:10566">HPV</span>
Similar to the association seen in UADT cancers, GST null genotype has been associated with the risk of developing Human Papilloma Virus (HPV)-positive primary cervical cancer in females [8,9] and also with other cancers such as primary breast cancer [10] and primary thyroid cancer [11].
###end p 6
###begin p 7
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 689 698 689 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 23 26 <span type="species:ncbi:10566">HPV</span>
###xml 144 147 <span type="species:ncbi:10566">HPV</span>
###xml 305 312 <span type="species:ncbi:4097">tobacco</span>
###xml 400 403 <span type="species:ncbi:10566">HPV</span>
###xml 587 590 <span type="species:ncbi:10566">HPV</span>
Females with a primary HPV related cancer (particularly uterine cervix) develop second cancers in the UADT with an increased frequency [12-14]. HPV transmission has been suggested to account in part for the paired occurrence of cancers at these anatomically distinct sites of UADT and cervix. Exposure to tobacco carcinogens has been suggested as synergistic cofactor [15,16]. The mechanism by which HPV infection, necessary for the development of cervical cancer [17], causes UADT cancers is unclear [18]. Recently it has been shown that interaction between viral infection (especially HPV) and xenobiotic enzymes such as GSTM1 could modulate cancer risk, however the evidence comes from in vitro studies alone [19].
###end p 7
###begin p 8
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 355 361 355 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 419 426 <span type="species:ncbi:4097">tobacco</span>
There are no studies found in the literature evaluating the association of GST null genotypes and the risk of developing second cancers in the UADT in females, particularly after primary cancers at genital sites. We identified females with a paired cancer in the UADT in association with another cancer (at all sites-genital and non-genital) and analyzed GSTM1 and T1 genotype in addition to known factors such as age, tobacco habits, alcohol habits and family history of cancer.
###end p 8
###begin title 9
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and methods
###end title 9
###begin title 10
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 10
###begin p 11
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
From a registry of 150 patients with Multiple Primary Neoplasms (MPN) at Tata Memorial Hospital, Mumbai, during the period of 1996 - 2004, all the females, who met the following criteria were selected: 1) synchronous or metachronous occurrence of second primary cancer; 2) Histological or cytological confirmation of both primaries; 3) One of the two cancers was a SCC in the UADT. Modified Hong's criteria [20] was used to differentiate the second primary cancer from metastatic or direct spread from the first cancer.
###end p 11
###begin p 12
###xml 131 138 <span type="species:ncbi:4097">tobacco</span>
###xml 275 282 <span type="species:ncbi:9606">patient</span>
###xml 364 371 <span type="species:ncbi:4097">tobacco</span>
Details about age, site of first cancer, site of second cancer, histology, grade, history of cancer in the first degree relatives, tobacco habits (smoking or smokeless), alcohol intake (regular, occasional or never) and radiotherapy for the first cancer were noted both from patient interviews and medical records. Detailed and exact quantification of exposure to tobacco and alcohol was not available in all cases. Neither were details about reproductive and sexual history available.
###end p 12
###begin title 13
DNA extraction
###end title 13
###begin p 14
Having obtained an informed consent, 5-10 ml of peripheral blood sample was collected in sterile EDTA tubes. The DNA was extracted from the leukocyte pellet obtained from the blood by sucrose lysis, purified by phenol: chloroform and suspended in Tris-EDTA buffer and stored at -20degreesc.
###end p 14
###begin title 15
PCR
###end title 15
###begin p 16
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 128 145 128 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Interferon&#946;-1 </italic>
###xml 151 160 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#946;-1</italic>
###xml 167 177 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#946;-1 </italic>
###xml 111 116 <span type="species:ncbi:9606">Human</span>
Multiplex Polymerase Chain reaction (PCR) was performed to simultaneously genotype GSTM1 or GSTT1 gene and the Human Fibroblast Interferonbeta-1 gene (IFNbeta-1). The IFNbeta-1 gene was used as an internal control for amplification failure. The primer sequences were as follows
###end p 16
###begin p 17
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
1) GSTM1: F: 5' CTG GAT TGT AGC AGA TCA TGC 3' and R: 5' CTG CCC TAC TTG ATT GAT GGG 3' which generates a 273 bp fragment;
###end p 17
###begin p 18
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1</italic>
2) GSTT1: F: 5' TTC CTT ACT GGT CCT CAC ATC TC 3' and R: 5' TCA CCG GAT CAT GGC CAG CA 3' which generates a 459 bp fragment and
###end p 18
###begin p 19
###xml 3 12 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#946;-1</italic>
3) IFNbeta-1: F: 5' GGC ACA ACA GGT AGT AGG CG 3' and R: 5' GCC ACA GGA GCT TCT GAC AC 3' which generates a 170 bp fragment.
###end p 19
###begin p 20
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 28 39 28 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Interferon </italic>
###xml 167 173 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 200 206 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 344 346 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 427 433 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 690 696 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
The GSTM1 or GSTT1 gene and Interferon gene were co-amplified in a 15 mul reaction mixture containing a total of 50 ng of genomic DNA as the template, 2.6 muM of each GSTM1 primer, or 2.6 muM of each GSTT1 primer, and 2.6 muM of each Interferon primer, 1.2 mM each dNTP, 1 x PCR buffer (which contained 20 mM Tris, pH 8.4, 50 mM KCl), 2 mM MgCl2 and 0.6 units of Taq polymerase (Amersham). The PCR profile for amplification of GSTM1 gene consisted of an initial melting step at 94degreesC for 9 min followed by 30 cycles at 94degreesC for 1 min, 55degreesC for 1 min, and 72degreesC for 1 min, with a final step at 72degreesC for 10 min for elongation. The PCR profile for amplification of GSTT1 gene consisted of an initial melting step at 95degreesC for 9 min followed by 30 cycles at 94degreesC for 1 min, 66degreesC for 1 min, and 72degreesC for 1 min, with a final step at 72degreesC for 10 min for elongation.
###end p 20
###begin title 21
Gel electrophoresis
###end title 21
###begin p 22
###xml 206 215 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IFN&#946;-1</italic>
###xml 260 265 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 278 283 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1</italic>
###xml 371 375 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
The PCR products were separated either on 2% agarose gels or on 12% polyacrylamide gels and were seen by ethidium bromide staining or silver staining respectively. In the PCR reaction presence of a 170 bp (IFNbeta-1) band alone and absence of a higher 273 bp (GSTM1) or 459 bp (GSTT1) band indicated null genotype of the sample. In the PCR assay when both Interferon and GST fragments were absent then it indicated that either the PCR was not successful or the DNA was degraded.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 136 143 <span type="species:ncbi:4097">tobacco</span>
Fishers exact test was used to assess the statistical significance for the difference between proportions of various factors (number of tobacco chewers, GSTM1 null, GSTT1 null, either GSTM1/T1 null).
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Overall data of all females
###end title 26
###begin p 27
###xml 806 812 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 818 824 818 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 840 849 840 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1/T1 </italic>
###xml 542 547 <span type="species:ncbi:9606">women</span>
###xml 622 627 <span type="species:ncbi:9606">women</span>
###xml 682 689 <span type="species:ncbi:4097">tobacco</span>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
Forty-nine females with a paired SCC in the UADT in association with another cancer (at genital and non-genital related sites) were identified. The median time to development of the paired cancer (or second cancer) was 4 years. The median age at diagnosis of first cancer in all females was 51 years and that of second cancer was 60 years. The commonest sites of first cancer were oral cavity (n = 17), genital region (n = 15), and esophagus including post-cricoid region (n = 12). Information on family history of cancer was available in 42 women and 6 (14.3%) had a first-degree relative affected with cancer. Of the 45 women where details of habits were available, 25 (56%) were tobacco chewers whereas only 1 (2%) smoked. Of the 29 patients in whom GSTM1 and T1 genotyping was done, the frequencies of GSTM1 null, GSTT1 null and either GSTM1/T1 null were 35%, 17% and 45% respectively.
###end p 27
###begin title 28
Groupwise analysis
###end title 28
###begin p 29
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 717 724 <span type="species:ncbi:4097">tobacco</span>
Results were further analyzed by dividing the females into two Groups (Table 1): Group 1 (n = 19), females who had a paired SCC in the UADT along with a cancer in the genital region and Group 2 (n = 30), females who had a paired SCC in the UADT along with a cancer at other sites (non-genital region). In the majority of the cases (80% in Group 1 and 86% in Group 2), UADT cancer occurred second in chronological order. The median time for the development of second cancer was 5-years (range 0-20 years) for females in Group 1 in comparison to 3-years (range 0-24 years) for females in Group 2. There were no significant differences in the median age at the diagnosis of the first cancer, family history of cancer or tobacco habits between the two groups. Uterine cervix was the commonest genital site of cancer in females in Group 1 (16/19, 84%), followed by vagina in one female, vaginal vault in one and vulva in one. The sites of second UADT cancer in females in Group 1 were: oral cavity (n = 7), oropharynx (n = 2), hypo pharynx (n = 1), trachea and Lung (n = 4), esophagus including post-cricoid (n = 4), thyroid (n = 1). In the females in Group 2, UADT was the commonest non-genital site of cancer (22/30, 73%), followed by breast (n = 6), duodenum (n = 1), and chronic lymphatic leukemia (n = 1). Histology of the cancer in the genital region in females in Group 1 was confirmed as SCC in the majority (18/19). In the remaining female the histology could not be confirmed as the records were missing, however it was confirmed that her cervical cancer was treated with radiotherapy, a treatment that is never given without histological confirmation at our hospital.
###end p 29
###begin p 30
Comparison of host, environment and treatment related parameters in the two Groups of females with second cancer in the UADT.
###end p 30
###begin p 31
###xml 45 52 <span type="species:ncbi:4097">tobacco</span>
* Except one smoker, all other habitues were tobacco chewers and none of them consumed alcohol.
###end p 31
###begin p 32
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1</italic>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M1 </italic>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 174 177 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
Null genotype frequencies for GSTT1, GSTM1 and either T1 or M1 were more frequent in Group 1 as compared to Group 2. The proportion of females who were null for either GSTM1/T1 were found to be significantly higher in the Group 1 than in Group 2.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 603 609 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1120 1126 1120 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 143 148 <span type="species:ncbi:9606">women</span>
###xml 242 245 <span type="species:ncbi:10566">HPV</span>
###xml 705 708 <span type="species:ncbi:10566">HPV</span>
###xml 756 759 <span type="species:ncbi:10566">HPV</span>
This is the first study evaluating the association of GST genotype with paired occurrence of an UADT cancer and genital site cancer. Of the 49 women with paired occurrence of an UADT SCC with a second cancer at any site, 19 (39%) were in the HPV related genital site. Majority (84%) of the genital cancers were in the Uterine Cervix and in more than half (68%) the genital cancer occurred before or within 6 months of development of the UADT cancer. Association between malignancies of the UADT and genital region (especially uterine cervix) has been observed by various investigators [13,15]. Hemminki et al [14] studied the pattern of second cancers in females and found a consistent increase in second HPV related cancer when the first cancer was at an HPV related site (anogenital, skin, head and neck, oesophageal and rectal cancers). An excess of oral cancers (including lip, mouth, tongue, larynx and pharynx), as found in this study, followed cervical cancers. Other investigators have also found similar results in the past [12]. Using incidence data from Surveillance, Epidemiology & End Results (SEER), Spitz et al [15] found an elevated Standardized Incidence Ratio (SIR) for cervical cancer after an initial buccal cavity cancer and larynx cancer.
###end p 34
###begin p 35
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
###xml 228 235 <span type="species:ncbi:4097">tobacco</span>
###xml 261 268 <span type="species:ncbi:4097">tobacco</span>
###xml 379 386 <span type="species:ncbi:4097">tobacco</span>
###xml 551 558 <span type="species:ncbi:4097">tobacco</span>
###xml 749 756 <span type="species:ncbi:4097">tobacco</span>
###xml 780 788 <span type="species:ncbi:9606">patients</span>
HPV transmission has been suggested to account in part for the paired occurrence of cancers at these anatomically distinct sites of UADT and cervix and smoking has been suggested as synergistic cofactor [15]. However, smokeless tobacco is a predominant form of tobacco consumed by females in India [21] and a recent study from India has shown a positive correlation of smokeless tobacco habits with cervical cancer risk [22]. Additionally, results from another study from India found more than 80% of oral cancers in females attributable to smokeless tobacco habit as compared to the negligible influence of smoking and drinking on oral cancer in females [23]. In concordance with these figures, 44% of females in Group 1 in our study had smokeless tobacco habits and none of the patients, except for one, smoked.
###end p 35
###begin p 36
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 668 674 668 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 859 865 859 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 1118 1124 1118 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 1207 1213 1207 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 1269 1275 1269 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 1379 1381 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1382 1384 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
###xml 968 975 <span type="species:ncbi:4097">tobacco</span>
The role of GST polymorphisms in the development of second cancers in the UADT has been a focus of few studies in various ethnic groups [4-7]. In all of these studies the GST null genotype (GSTM1 and or GSTT1) has been seen with increased frequency in patients with second cancers in the UADT as compared to those with single cancers in the UADT. The results of the recently published meta and pooled analysis support the notion of a greater risk of head and neck cancer when genotypes at multiple GST loci are considered [3]. The 35% GSTM1 null genotype frequency (in entire population of females with second cancers in the UADT) in this study is very similar to the GSTM1 null genotype frequency of 36% found in our previous study in male patients with second cancers in the UADT from similar ethnic background [7]. However, the null genotype frequency for GSTT1 in males was 41% vs. 17% in females from this study. Differences in the site of cancer and the form of tobacco use, which predisposes to cancer development at a particular site, between males and females might possibly explain the gender discordance in GSTT1 null genotype frequencies. Nonetheless the 41% and 17% null genotype frequency for GSTT1 in males and females respectively are higher than 8-12% GSTT1 null genotype frequency found in healthy controls from similar ethnicity suggesting a true association [24,25].
###end p 36
###begin p 37
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
GSTM1 and GSTT1 null genotype frequencies (54% and 33%) in the females who had second cancer in the UADT in association with a cancer in the genital region (Group 1) in the present study are higher than a) the respective frequencies (22% & 6%) in females with second cancer in the UADT in association with a cancer at non-genital region (Group 2), b) the respective frequencies (49% & 18%) found in subjects with single UADT cancers in two studies from a similar ethnic background [24,25], c) the respective frequencies (26% & 19%) found in males with single UADT cancers from our previous study [7], and d) the respective frequencies (33% & 8% and 24% & 12%) found in Indian healthy controls [24,25]. This suggests that the females who developed second cancers in the UADT in association with cancer at genital sites (Group 1 in this study) are possibly more susceptible to damage induced by carcinogens.
###end p 37
###begin p 38
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 546 552 546 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T1 </italic>
###xml 852 858 852 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 893 899 893 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 1031 1037 1031 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 1208 1214 1208 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 1327 1333 1327 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 285 292 <span type="species:ncbi:9606">patient</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
###xml 745 753 <span type="species:ncbi:9606">patients</span>
###xml 840 845 <span type="species:ncbi:9606">women</span>
The association of GST polymorphism and the risk of single primary cervical SCC have been studied in female patients from various ethnicities. GSTM1 null genotype has been found to incur an increased risk for primary cervical cancer in a mixed Caucasian, Hispanic and African-American patient population as compared to controls [9]. Like wise, in a study on 181 Korean cervical carcinoma patients, Kim et al [8], showed a positive correlation between GST genotypes and cervical carcinoma risk as compared to controls. In this study by Kim et al, GSTT1 null genotype was associated with an increased risk for cervical cancer. When the patients were stratified according to age, either GSTM1/T1 null genotype was significantly over represented in patients with cervical carcinoma who were = 40 years old. However, in a study on 190 Caucasian women, Chen et al [26], determined no association of GSTM1 null genotype with invasive cervical cancer risk. Other investigators have found results similar to that found in the study by Chen et al [26-28]. Differences in GST genotype frequencies in various control populations could account for the differences seen in various studies. For instance, the prevalence of GSTM1 null genotype in Caucasian, American and Korean population is similar (as high as 50%) whereas the prevalence of GSTT1 null genotypes varies from 15-31% in the Caucasians to 50-58% in the Koreans and Chinese.
###end p 38
###begin p 39
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTT1 </italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
In view of the known differences of the population frequency of null genotypes and its associated risks for cervical cancer across various ethnic groups, it is important to compare our results with those from studies conducted on subjects from a similar ethnic background. GSTM1 and GSTT1 null genotype frequencies (54% and 33% respectively) in the females who had at least one of the cancers in the genital region (Group 1) in the present study were similar to the respective frequencies (57% and 20% respectively) found in females with single (unpaired) cervical cancer cases from India [29] suggesting that the association between GST genotype and cervical cancer risk in Group 1 females in our study is more likely to be a true association.
###end p 39
###begin p 40
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1</italic>
###xml 1284 1288 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 1368 1374 1368 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSTM1 </italic>
###xml 1504 1505 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1589 1593 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 1626 1632 1626 1632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1633 1634 1633 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 3 <span type="species:ncbi:10566">HPV</span>
###xml 84 87 <span type="species:ncbi:10566">HPV</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 212 215 <span type="species:ncbi:10566">HPV</span>
###xml 305 308 <span type="species:ncbi:10566">HPV</span>
###xml 349 356 <span type="species:ncbi:4097">tobacco</span>
###xml 414 417 <span type="species:ncbi:10566">HPV</span>
###xml 459 462 <span type="species:ncbi:10566">HPV</span>
###xml 543 551 <span type="species:ncbi:9606">patients</span>
###xml 590 593 <span type="species:ncbi:10566">HPV</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
###xml 626 629 <span type="species:ncbi:10566">HPV</span>
###xml 696 699 <span type="species:ncbi:10566">HPV</span>
###xml 1333 1336 <span type="species:ncbi:10566">HPV</span>
###xml 1410 1413 <span type="species:ncbi:10566">HPV</span>
###xml 1525 1533 <span type="species:ncbi:9606">patients</span>
###xml 1637 1640 <span type="species:ncbi:10566">HPV</span>
HPV is undoubtedly the main causative agent in cervical SCC's and the prevalence of HPV, mainly HPV16/18 of more than 95%, has been seen in tumours from cervical cancer patients from India [30]. Evidence linking HPV to oral carcinogenesis is also growing and one of the highest prevalence rates of 74% of HPV 16 and 18 in oral tumors from smokeless tobacco habitues have been reported from southern India [31]. As HPV infections are transient, the absence of HPV DNA does not rule out previous exposure [32]. Interestingly, though most of the patients with cervical cancer are positive for HPV [17], not all patients who have HPV infection will go on to develop cancer [33]. Interactions between HPV and GST genotype may be a reason for this. The evidence for this is two-way. Chen et al [19] evaluating the reason for the lack of association between GSTM1 null genotypes and cervical cancer risk in their epidemiological study demonstrated that viral infection could have potential effect on the activity of xenobiotic metabolizing enzymes, particularly GSTM1. The results of their study raised a question of how chronic viral infections could affect cellular defenses against carcinogens in general. Evidence from other studies suggests that inherited susceptibility in the form of GST genotype may modulate the risk of developing HPV related cancer as evidenced by GSTM1 null genotype which, in addition to HPV infection and smoking, has been found to increase the risk of developing cervical cancer [9]. Moreover, in the patients with cervix cancers having a positive association with GST null genotype, as studied by Kim et al [8], HPV 16 or 18 infections were confirmed in all.
###end p 40
###begin title 41
Conclusion
###end title 41
###begin p 42
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST </italic>
###xml 132 135 <span type="species:ncbi:10566">HPV</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
The findings of our study suggest an association between the GST null genotype and the occurrence of paired cancers in the UADT and HPV related genital sites in females. Though this is the first study to report such an association, further confirmation from larger studies on patients from different ethnic backgrounds is required.
###end p 42
###begin title 43
Acknowledgements
###end title 43
###begin p 44
SGJ would like to thank his wife, Sudha, for her help with preparation of the manuscript.
###end p 44
###begin article-title 45
Multiple Cancers of the Upper Aero-Digestive Tract: the Challenge of Risk Factor Identification
###end article-title 45
###begin article-title 46
The Glutathione S-Transferase Supergene Family: Regulation of GST and the Contribution of the Isoenzymes to Cancer Chemoprotection and Drug Resistance
###end article-title 46
###begin article-title 47
Meta- and Pooled Analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes and Risk of Head and Neck Cancer
###end article-title 47
###begin article-title 48
[First Results on the Influence of Polymorphisms at Glutathione S-Transferase, Cytochrome P450, and Tumor Necrosis Factor Gene Loci on the Development of Multiple Head and Neck Cancer]
###end article-title 48
###begin article-title 49
Glutathione-S-Transferase Polymorphisms and Risk of Squamous-Cell Carcinoma of the Head and Neck
###end article-title 49
###begin article-title 50
Genetic Polymorphisms of Drug-Metabolizing Enzymes and Susceptibility to Head-and-Neck Squamous-Cell Carcinoma
###end article-title 50
###begin article-title 51
###xml 164 171 <span type="species:ncbi:4097">Tobacco</span>
Glutahione S-Transferase MI or T1 Null Genotype As a Risk Factor for Developing Multiple Primary Neoplasms in the Upper Aero-Digestive Tract, in Indian Males Using Tobacco
###end article-title 51
###begin article-title 52
Combined Analysis of Germline Polymorphisms of P53, GSTM1, GSTT1, CYP1A1, and CYP2E1: Relation to the Incidence Rate of Cervical Carcinoma
###end article-title 52
###begin article-title 53
Polymorphisms for Chemical Metabolizing Genes and Risk for Cervical Neoplasia
###end article-title 53
###begin article-title 54
The Role of Polymorphic Genes Involved in Oestrogen Biosynthesis and Metabolism
###end article-title 54
###begin article-title 55
The Null Genotype of Glutathione S-Transferase M1 and T1 Locus Increases the Risk for Thyroid Cancer
###end article-title 55
###begin article-title 56
Second Primary Cancers Following Anal and Cervical Carcinoma: Evidence of Shared Etiologic Factors
###end article-title 56
###begin article-title 57
###xml 26 34 <span type="species:ncbi:9606">Patients</span>
Second Primary Cancers in Patients With Carcinoma in Situ of the Uterine Cervix. The Norwegian Experience 1970-1992
###end article-title 57
###begin article-title 58
Second Primary Cancers After Anogenital, Skin, Oral, Esophageal and Rectal Cancers: Etiological Links?
###end article-title 58
###begin article-title 59
Association Between Malignancies of the Upper Aerodigestive Tract and Uterine Cervix
###end article-title 59
###begin article-title 60
Smoking and Cervical Cancer: Pooled Analysis of the IARC Multi-Centric Case - Control Study
###end article-title 60
###begin article-title 61
###xml 11 16 <span type="species:ncbi:9606">Human</span>
Chapter 1: Human Papillomavirus and Cervical Cancer - Burden and Assessment of Causality
###end article-title 61
###begin article-title 62
###xml 11 16 <span type="species:ncbi:9606">Human</span>
Chapter 7: Human Papillomavirus and Cancer of the Upper Aerodigestive Tract
###end article-title 62
###begin article-title 63
###xml 74 79 <span type="species:ncbi:9606">Human</span>
Decreased Expression of Glutathione S-Transferase M1 in HPV16-Transfected Human Cervical Keratinocytes in Culture
###end article-title 63
###begin article-title 64
Prevention of Second Primary Tumors With Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
###end article-title 64
###begin article-title 65
###xml 0 7 <span type="species:ncbi:4097">Tobacco</span>
###xml 50 59 <span type="species:ncbi:184783">areca-nut</span>
###xml 155 161 <span type="species:ncbi:9606">humans</span>
Tobacco habits other than smoking: betel-quid and areca-nut chewing and some related nitrosamines; Monograph on the evaluation of the carcinogenic risk to humans
###end article-title 65
###begin article-title 66
Role of Paan Chewing and Dietary Habits in Cervical Carcinoma in Chennai, India
###end article-title 66
###begin article-title 67
Oral Cancer in Southern India: the Influence of Smoking, Drinking, Paan-Chewing and Oral Hygienet
###end article-title 67
###begin article-title 68
Genetic Polymorphism of CYP1A1, GSTM1 and GSTT1 Genes in Indian Oral Cancer
###end article-title 68
###begin article-title 69
Polymorphism at GSTM1, GSTM3 and GSTT1 Gene Loci and Susceptibility to Oral Cancer in an Indian Population
###end article-title 69
###begin article-title 70
Glutathione S-Transferase M1 Genotypes and the Risk of Squamous Carcinoma of the Cervix: a Population-Based Case-Control Study
###end article-title 70
###begin article-title 71
Theta Class Glutathione S-Transferase GSTT1 Genotypes and Susceptibility to Cervical Neoplasia: Interactions With GSTM1, CYP2D6 and Smoking
###end article-title 71
###begin article-title 72
CYP1A1, GSTM1, and GSTT1 Polymorphisms and the Risk of Cervical Squamous Intraepithelial Lesions in a Multiethnic Population
###end article-title 72
###begin article-title 73
Polymorphisms at GSTM1 and GSTT1 Gene Loci and Susceptibility to Cervical Cancer in Indian Population
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Papillomavirus and Risk Factors for Cervical Cancer in Chennai, India: a Case-Control Study
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Papillomaviruses in 91 Oral Cancers From Indian Betel Quid Chewers - High Prevalence and Multiplicity of Infections
###end article-title 75
###begin article-title 76
###xml 23 26 <span type="species:ncbi:10566">HPV</span>
###xml 63 68 <span type="species:ncbi:9606">Women</span>
Transience of Cervical HPV Infection in Sexually Active, Young Women With Normal Cervicovaginal Cytology
###end article-title 76
###begin article-title 77
###xml 24 29 <span type="species:ncbi:9606">Human</span>
###xml 82 87 <span type="species:ncbi:9606">Women</span>
Determinants of Genital Human Papillomavirus Infection Among Cytologically Normal Women Attending the University of New Mexico Student Health Center
###end article-title 77

